Fig. 01 -

Title Slide

Fig. 02 -

Polio Epedemic

Fig. 03 -

Goals of NPPV

Fig. 04 -

Effects and Outcomes

Fig. 05 -

Trends

Fig. 06 -

Utilization

Fig. 07 -

Interfaces

Fig. 08 -

Oronasal

Fig. 09 -

Nasal Pillows

Fig. 10 -

Chronic Stable COPD

Fig. 11 -

Nocturnal NPPV

Fig. 12 -

Changes in PaCO₂

Fig. 13 -

Readmission or Death

Fig. 14 -

Control vs Intervention

Fig. 15 -

Significant Features

Fig. 16 -

Summary of Data

Fig. 17 -

Settings & Mortality

Fig. 18 -

Factors & Outcomes

Fig. 19 -

High Intensity

Fig. 20 -

Hi vs Low NPPV in COPD

Fig. 21 -

Home NMV

Fig. 22 -

Consort Diagram

Fig. 23 -

Study Outcomes

Fig. 24 -

Baseline Demographics

Fig. 25 -

Baseline Status

Fig. 26 -

Comorbidities

Fig. 27 -

Use and Survival

Fig. 28 -

Secondary Endpoints

Fig. 29 -

Long-term adherence

Fig. 30 -

Obese COPD

Fig. 31 -

Enhanced survival

Fig. 32 -

RCT & Training

Fig. 33 -

Transitioning

Fig. 34 -

Transitioning (cont.)

Fig. 35 -

Summary